JP2016519101A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016519101A5 JP2016519101A5 JP2016505926A JP2016505926A JP2016519101A5 JP 2016519101 A5 JP2016519101 A5 JP 2016519101A5 JP 2016505926 A JP2016505926 A JP 2016505926A JP 2016505926 A JP2016505926 A JP 2016505926A JP 2016519101 A5 JP2016519101 A5 JP 2016519101A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- omega
- acid
- fatty acid
- fatty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361808246P | 2013-04-04 | 2013-04-04 | |
| US61/808,246 | 2013-04-04 | ||
| PCT/IL2014/050329 WO2014162313A1 (en) | 2013-04-04 | 2014-04-03 | Anti-inflammatory synergistic combinations comprising omega-3 fatty acid and tomato lycopene |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018224936A Division JP6803898B2 (ja) | 2013-04-04 | 2018-11-30 | オメガ−３脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016519101A JP2016519101A (ja) | 2016-06-30 |
| JP2016519101A5 true JP2016519101A5 (cg-RX-API-DMAC7.html) | 2017-05-18 |
Family
ID=51657661
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016505926A Pending JP2016519101A (ja) | 2013-04-04 | 2014-04-03 | オメガ−３脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ |
| JP2018224936A Expired - Fee Related JP6803898B2 (ja) | 2013-04-04 | 2018-11-30 | オメガ−３脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018224936A Expired - Fee Related JP6803898B2 (ja) | 2013-04-04 | 2018-11-30 | オメガ−３脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9901562B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2981256B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2016519101A (cg-RX-API-DMAC7.html) |
| CN (1) | CN105407885B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014246728B2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2932248T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014162313A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9901562B2 (en) * | 2013-04-04 | 2018-02-27 | Lycored Ltd. | Anti-inflammatory omega-3 synergistic combinations |
| CN108354919A (zh) * | 2017-12-29 | 2018-08-03 | 广东海洋大学 | 一种用于提高抗氧化功能的不饱和脂肪酸组合物及其应用 |
| CN111053248A (zh) * | 2018-10-16 | 2020-04-24 | 东莞市维康医疗投资有限公司 | 一种地龙蛋白口服液及其制备方法 |
| WO2021072311A1 (en) | 2019-10-09 | 2021-04-15 | Braini Llc | Compositions with purified bombyx mori cocoon silk peptide fiber and refined buglossoides arvensis seed oil, and related methods |
| US11707497B2 (en) | 2019-10-09 | 2023-07-25 | Brain Health Holding Llc | Methods and compositions with purified Bombyx mori cocoon silk peptide fiber and refined Buglossoides arvensis seed oil providing anti-inflammatory effects and neuroprotection for disease states |
| WO2021070184A1 (en) * | 2019-10-10 | 2021-04-15 | Lycored Ltd. | Compositions and methods for inhibiting collagen loss |
| US20250213640A1 (en) * | 2024-01-03 | 2025-07-03 | Hazel's Holistic, Llc | Methods And Kits For Reducing Microplastics Levels And/Or Reducing Or Minimizing Microplastics Accumulation Rates In Subjects |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5837311A (en) | 1993-12-13 | 1998-11-17 | Makhteshim Chemical Works Ltd. | Industrial processing of tomatoes and product thereof |
| EP0938846B1 (fr) | 1998-02-13 | 2004-04-14 | Societe Des Produits Nestle S.A. | Toast garni |
| US20020146400A1 (en) * | 2000-01-07 | 2002-10-10 | Cincotta Anthony H. | Composition for reducing plasma triglycerides, platelet aggregation, and oxidative capacity |
| AU2003205737A1 (en) | 2002-02-15 | 2003-09-04 | Humboldt Universitaet | Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies |
| JP2009537467A (ja) | 2006-05-15 | 2009-10-29 | ディーエスエム アイピー アセッツ ビー．ブイ． | 前立腺癌に対する新規活性物 |
| KR20090109793A (ko) * | 2008-04-16 | 2009-10-21 | 홉킨스바이오연구센터(주) | 크랜베리 추출물 또는 복분자 추출물을 함유하는건강기능성식품 조성물 |
| CN105193777B (zh) | 2009-01-19 | 2019-06-28 | 利科雷德有限公司 | 类胡萝卜素和多酚的协同组合 |
| US20110008901A1 (en) | 2009-07-07 | 2011-01-13 | Kiernan Urban A | Apolipoprotein ciii in pre- and type 2 diabetes |
| KR20120115965A (ko) | 2009-11-06 | 2012-10-19 | 알콘 리서치, 리미티드 | 안구 건조의 완화를 위한 영양 보충제 |
| AU2014233756B2 (en) * | 2013-03-19 | 2017-02-02 | Lycored Ltd. | Astaxanthin anti-inflammatory synergistic combinations |
| US9901562B2 (en) * | 2013-04-04 | 2018-02-27 | Lycored Ltd. | Anti-inflammatory omega-3 synergistic combinations |
-
2014
- 2014-03-04 US US14/782,583 patent/US9901562B2/en active Active
- 2014-04-03 ES ES14778751T patent/ES2932248T3/es active Active
- 2014-04-03 AU AU2014246728A patent/AU2014246728B2/en not_active Ceased
- 2014-04-03 EP EP14778751.9A patent/EP2981256B1/en active Active
- 2014-04-03 JP JP2016505926A patent/JP2016519101A/ja active Pending
- 2014-04-03 CN CN201480024636.8A patent/CN105407885B/zh active Active
- 2014-04-03 WO PCT/IL2014/050329 patent/WO2014162313A1/en not_active Ceased
-
2017
- 2017-12-04 US US15/830,402 patent/US10154980B2/en active Active
-
2018
- 2018-11-30 JP JP2018224936A patent/JP6803898B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016519101A5 (cg-RX-API-DMAC7.html) | ||
| ES2666322T3 (es) | Composiciones farmacéuticas para el tratamiento de trastornos musculares | |
| AR103260A1 (es) | Modulación inmunitaria | |
| MX359711B (es) | Composiciones de éster de ácido graso omega-3. | |
| CL2017001614A1 (es) | Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-3 poliinsaturados | |
| CL2015002713A1 (es) | Métodos para mejorar la calidad de la composición del meibo de las glándulas de meibomio. | |
| MX2014000770A (es) | Composiciones de acidos grasos. | |
| AR098882A1 (es) | Composición dentífrica que comprende óxido de zinc y citrato de zinc | |
| MX2017007266A (es) | Implemento para el cuidado bucal con un mango de componentes multiples. | |
| DK3149105T3 (da) | Anvendelse af syntetiske syresammensætninger som alternativer til konventionelle syrer i olie- og gasindustrien | |
| WO2014165190A3 (en) | Compositions comprising docosapentaenoic acid and methods of use | |
| CR20170320A (es) | Mezcla de ácidos carboxílicos para tratar pacientes con insuficiencia renal | |
| AR097146A1 (es) | Composición para alimentación de rumiantes y método para prepararla | |
| GEP201606568B (en) | Compositions for the treatment of neurologic disorders | |
| CL2017001613A1 (es) | Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-6 poliinsaturados | |
| MX363035B (es) | Uso de una composicion que comprende aceite de pescado y jugo para el tratamiento de inflamacion. | |
| CY1123942T1 (el) | Συνθεσεις ωμεγα-3 λιπαρων οξεων για τη θεραπεια ασθενειων που επιφερουν βλαβη στο νευρικο συστημα | |
| ZA201702385B (en) | Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states | |
| EP4356962A3 (en) | Selective il-6-trans-signalling inhibitor compositions | |
| BR112016028518A2 (pt) | composições farmacêuticas que compreendem dgla e uso do mesmo | |
| WO2016040570A3 (en) | Dietary emulsion formulations and methods for using the same | |
| CO2017001088A2 (es) | Mezcla de ácidos grasos y palmitoiletanolamida para su uso en el tratamiento de patologías inflamatorias y alérgicas | |
| MX2015007085A (es) | Composiciones de acido omega-3 pentanoico y metodos de uso. | |
| PL3784044T3 (pl) | Kompozycje wielonienasyconych kwasów tłuszczowych wzbogacone w dha | |
| CL2016003131A1 (es) | Composiciones de omega-3, formas de dosis, y métodos de uso |